Saturday, December 10, 2022
News

WHO flags four 'substandard' India-made paediatric medicines in west Africa

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Geneva | Thursday, 2022 3:45:10 AM IST
The World Health Organization on Wednesday issued an alert for four "contaminated" India-made medicines, chiefly for paediatric use, identified in the west African nation of The Gambia and found to contain chemicals that are toxic and potentially fatal.

A WHO Medical Product Alert said that the four substandard products, reported to it in September, are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup, all stated to be manufactured by Maiden Pharmaceuticals Ltd located in Haryana.

Noting that the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products, the alert said that laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol, both "toxic to humans when consumed and can prove fatal".

"The substandard products referenced in this alert are unsafe and their use, especially in children, may result in serious injury or death," it said, adding that the toxic effects can include abdominal pain, vomiting, diarrhoea, inability to pass urine, headache, altered mental state, and acute kidney injury which may lead to death.

All batches of these products should be considered unsafe until they can be analysed by the relevant national regulatory authorities, the WHO said.

While these four products have been identified in The Gambia, it apprehended that they may have been distributed, through informal markets, to other countries or regions, and it "is important to detect and remove these substandard products from circulation to prevent harm to patients".

WHO requests increased surveillance and diligence within the supply chains of countries and regions likely to be affected by these products. Increased surveillance of the informal/unregulated market is also advised, the alert said.

It underlined that all medical products must be approved and obtained from authorised/licensed suppliers, the products' authenticity and physical condition should be carefully checked, and advice taken from a healthcare professional when in doubt.

"If you have these substandard products, please DO NOT use them. If you, or someone you know, have used these products or suffered any adverse reaction/event after use, you are advised to seek immediate medical advice from a qualified healthcare professional and report the incident to the National Regulatory Authority or National Pharmacovigilance Centre," the alert said.

"National regulatory/health authorities are advised to immediately notify WHO if these substandard products are discovered in their respective country," it added.

--IANS vd/arm

( 417 Words)

2022-10-05-21:42:01 (IANS)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE HEALTH NEWS
AIIA Goa to open new pastures of medical...
Covid-related disruptions delayed cancer...
Boy with twisted intestines gets new lea...
Indians report unexpected rise in heart ...
Study: Risk of heart disease can be redu...
Researchers discover how oxytocin drives...
More...
 
INDIA WORLD ASIA
No complaint about EVMs, no repolling, b...
Kerala CPI-M warms up to Indian Union Mu...
Cyclone Mandous to complete landfall wit...
Guj polls: Massive seizure worth Rs 801....
CM Bhagwant Mann assures PM Modi of succ...
Assam: Several houses gutted in massive ...
More...    
 
 Top Stories
Elton John says he will "no longer ... 
G20 presidency matter of pride for ... 
Xi Jinping ensures "complete contro... 
"That's a pity": Netherlands manage... 
Study: Risk of heart disease can be... 
FIFA WC: Lionel Messi slams Netherl... 
India remains "concerned on volatil... 
Not Pratibha Singh but these 3 Cong...